- Home
- HKIT vs SCLX Comparison
HKIT vs SCLX Comparison
Compare HKIT & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- SCLX
- Stock Information
- Founded
- HKIT 1996
- SCLX 2011
- Country
- HKIT China
- SCLX United States
- Employees
- HKIT N/A
- SCLX N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- SCLX Health Care
- Exchange
- HKIT Nasdaq
- SCLX Nasdaq
- Market Cap
- HKIT 34.9M
- SCLX 28.4M
- IPO Year
- HKIT 2023
- SCLX N/A
- Fundamental
- Price
- HKIT $1.25
- SCLX $4.55
- Analyst Decision
- HKIT
- SCLX Strong Buy
- Analyst Count
- HKIT 0
- SCLX 4
- Target Price
- HKIT N/A
- SCLX $396.67
- AVG Volume (30 Days)
- HKIT 16.4K
- SCLX 174.0K
- Earning Date
- HKIT 04-29-2025
- SCLX 05-14-2025
- Dividend Yield
- HKIT N/A
- SCLX N/A
- EPS Growth
- HKIT N/A
- SCLX N/A
- EPS
- HKIT N/A
- SCLX N/A
- Revenue
- HKIT $2,904,950.00
- SCLX $50,710,000.00
- Revenue This Year
- HKIT N/A
- SCLX $115.30
- Revenue Next Year
- HKIT N/A
- SCLX $73.33
- P/E Ratio
- HKIT N/A
- SCLX N/A
- Revenue Growth
- HKIT N/A
- SCLX 7.79
- 52 Week Low
- HKIT $1.15
- SCLX $3.60
- 52 Week High
- HKIT $2.18
- SCLX $80.50
- Technical
- Relative Strength Index (RSI)
- HKIT 52.36
- SCLX 41.40
- Support Level
- HKIT $1.16
- SCLX $4.02
- Resistance Level
- HKIT $1.25
- SCLX $5.31
- Average True Range (ATR)
- HKIT 0.07
- SCLX 0.55
- MACD
- HKIT 0.00
- SCLX 0.20
- Stochastic Oscillator
- HKIT 52.99
- SCLX 41.10
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.